Safety and efficacy of long-term treatment with fluticasone propionate and salmeterol via DISKUS versus fluticasone propionate alone

Clinical Research and Regulatory Affairs

Volumn 28, Issue 1, 2011, Pages 14-21

  Kerwin, Edward ^a   Prazma, Charlene M ^b   Sutton, Laura ^b   Stempel, David A ^b  

^a Clinical Research Institute   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

asthma attacks; asthma control; exacerbations; Fluticasone propionate; long term; salmeterol

Indexed keywords

FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL;

ADULT; ARTICLE; ASTHMA; BRONCHITIS; CANDIDIASIS; COUGHING; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LONG TERM CARE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PEAK EXPIRATORY FLOW; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SINUSITIS; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION;

EID: 79952160637     PISSN: 10601333     EISSN: 15322521     Source Type: Journal    
DOI: 10.3109/10601333.2010.544315     Document Type: Article

References (21)

1. Condemi JJ, Goldstein S, Kalberg C, Yancey S, Emmett A, Rickard K. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group. Ann Allergy Asthma Immunol 1999;82:383-389. (Pubitemid 29203287)
2. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet 1994;344:219-224. (Pubitemid 24229008)
3. Kelsen SG, Church NL, Gillman SA, Lanier BQ, Emmett AH, Rickard KA, Anderson WH. Salmeterol added to inhaled corticosteroid therapy is superior to doubling the dose of inhaled corticosteroids: a randomized clinical trial. J Asthma 1999;36:703-715. (Pubitemid 30012845)
4. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996;153:1481-1488. (Pubitemid 26141329)
5. Murray JJ, Church NL, Anderson WH, Bernstein DI, Wenzel SE, Emmett A, Rickard KA. Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases. Allergy Asthma Proc 1999;20:173-180.
6. National Institutes of Health. National Asthma Education and Prevention Program. Expert Panel Report 3: guidelines for the diagnosis and management of asthma. August 2007. NIH publication no. 07-4051 Available at: http://wwwnhlbinihgov/ guidelines/asthma/indexhtm. Accessed September 10, 2010.
7. Global Initiative for Asthma. Global strategy for Asthma Management and Prevention, revised 2008. Available online at: http://www.ginasthma.com/ Guidelineitem.asp??l1=2&l2=2008. Accessed September 10, 2010
8. Bateman E, Nelson H, Bousquet J, Kral K, Sutton L, Ortega H, Yancey S. Meta-analysis: effects of adding salmeterol to inhaled corticosteroids on serious asthma-related events. Ann Intern Med 2008;149:33-42.
9. Masoli M, Weatherall M, Holt S, Beasley R. Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax 2005;60:730-734. (Pubitemid 41297891)
10. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pedersen SE. Can guideline-defined asthma control be achieved? The gaining optimal asthma control study. Am J Respir Crit Care Med 2004;170:836-844. (Pubitemid 39346477)
11. Lundback B, Ronmark E, Lindberg A, Jonsson AC, Larsson LG, Petavy F, James M. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate. Respir Med 2006;100:2-10. (Pubitemid 43033373)
12. Proceedings of the ATS workshop on refractory asthma: current understanding recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med 2000;162:2341-2351.
13. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159:179-187. (Pubitemid 29036522)
14. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988;75:800-802.
15. Kavuru M, Melamed J, Gross G, Laforce C, House K, Prillaman B, Baitinger L, Woodring A, Shah T. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2000;105:1108-1116. (Pubitemid 30418788)
16. Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists. Ann Allergy Asthma Immunol 2004;93:351-359. (Pubitemid 39382976)
17. Nelson HS, Wolfe JD, Gross G, Greos LS, Baitinger L, Scott C, Dorinsky P. Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment. Ann Allergy Asthma Immunol 2003;91:263-269. (Pubitemid 37174159)
18. Shapiro G, Lumry W, Wolfe J, Given J, White MV, Woodring A, Baitinger L, House K, Prillaman B, Shah T. Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma. Am J Respir Crit Care Med 2000;161:527-534. (Pubitemid 30129463)
19. Lim KG, Rank MA, Li JT, Patel A, Volcheck GW, Branda ME, Cabanela R, Naessens JM, Shah ND, Wagie A, Beebe T. How well does patient self-report predict asthma medication possession? Implications for medication reconciliation and adherence assessment. J Asthma 2010;epub date 2010/09/14.
20. Katial RK, Bernstein D, Prazma CM, Lincourt W, Stempel DA. Long-term treatment with fluticasone propionate (FP) and salmeterol via DISKUS (FSC) improves asthma control versus fluticasone propionate (FP) alone. Am J Respir Crit Care Med 2010;181:A6652.
21. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, de Jongste JC, Kerstjens HA, Lazarus SC, Levy ML, O'Byrne PM, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Sullivan SD, Szefler SJ, Thomas MD, Wenzel SE. An official American Thoracic Society/ European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009;180:59-99.